Insmed

Insmed’s shares double as lung disease med powers past expectations in phase 3
Fierce Biotech
Tue, 05/28/24 - 10:57 am
Insmed
bronchiectasis
clinical trials
brensocatib
Insmed’s brensocatib: A candidate for bronchiectasis treatment, closer to approval
Clinical Trials Arena
Wed, 05/8/24 - 11:12 am
Insmed
brensocatib
bronchiectasis
clinical trials
Insmed Drug for Rare Pulmonary Disorder Meets Phase 2 Goals
Xconomy
Mon, 02/3/20 - 11:56 pm
Insmed
clinical trials
non-cystic fibrosis bronchiectasis
INS1007
The 3 Best-Performing Biotech Stocks at the J.P. Morgan Healthcare Conference
Motley Fool
Fri, 01/11/19 - 09:59 am
Loxo Oncology
SAGE Therapeutics
Insmed
Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates
Yahoo/Benzinga
Sat, 09/1/18 - 03:38 pm
biotech
FDA
Roche
Tecentriq
GSK
mepolizumab
Teva Pharmaceutical
fremanezumab
Adamis Pharmaceuticals
Symjepi
Insmed
ALIS
Antares
XYOSTED
Eli Lilly
galcanezumab
Pfizer
dacomitinib
The Week Ahead In Biotech: Conferences, PDUFA Dates And IPOs
Yahoo/Benzinga
Sun, 08/5/18 - 07:25 pm
biotech
IPOs
Pain Therapeutics
Remoxy
Vertex Pharmaceuticals
lumacaftor/ivacaftor
Alnylam
Patisiran
Regeneron
Eylea
Insmed
Paratek
Vaccinex
3 Biotech Stocks That Skyrocketed This Week: Can They Go Higher?
Motley Fool
Sat, 09/9/17 - 02:55 pm
biotech
Insmed
NewLink Genetics
Voyager Therapeutics
ALIS
indoximod/Keytruda
VY-AADC01
Insmed shares soar as PhIII lung disease study proves positive, pointing to quick FDA pitch
Endpoints
Tue, 09/5/17 - 10:16 pm
Insmed
clinical trials
Arikayce
ALIS
AstraZeneca licenses respiratory drug to Insmed
Yahoo/Reuters
Wed, 10/5/16 - 09:35 am
AstraZeneca
Insmed
AZD7986
Respiratory
Insmed reports 2Q loss
Yahoo/AP
Thu, 08/6/15 - 10:22 am
Insmed
earnings
As Antibiotics Stop Working, Five Biotechs Seek Cures
24/7 Wall St
Fri, 06/20/14 - 12:31 pm
antibiotic resistance
antibiotics
Cubist Pharmaceuticals
Durata
Insmed
Medicines Company
Tetraphase Pharmaceuticals
8 Biotech Events To Anticipate This Year: Part One
Seeking Alpha
Tue, 04/8/14 - 09:46 am
Zohydro
Zogenix
Zybrestat
Oxigene
Arikayce
Insmed
obeticholic acid
Intercept Pharmaceuticals
Insmed's lung infection drug fails mid-stage study
Yahoo/Reuters
Wed, 03/26/14 - 08:03 am
Insmed
Arikace
nontuberculous mycobacterial lung infections
Teva Acquisition Machine Gears Up: Who Is the Next Target?
Yahoo/24-7 Wall St
Wed, 01/22/14 - 08:41 am
Teva Pharmaceuticals
M&A
Idenix
Insmed
NuPathe
InterMune
Puma Biotechnology
UBS Has Nine Biotech Buyout and Merger Candidates
24/7 Wall St
Tue, 01/14/14 - 09:07 am
biotech
M&A
Alexion
Biomarin
Incyte
Medivation
Idenix
Insmed
InterMune
Puma Biotechnology
Vertex Pharmaceuticals
Problems Found With Insmed's Analysis of Arikace Cystic Fibrosis Study
TheStreet.com
Tue, 10/22/13 - 08:30 am
Insmed
Arikace
cystic fibrosis
New Patents for Insmed's Arikace
Yahoo/Zacks
Tue, 09/17/13 - 09:50 am
patents
Insmed
Arikace
Our BioPharma Catalyst Watch List
Seeking Alpha
Thu, 08/15/13 - 12:09 pm
Astex
Biodel
Insmed
MannKind
Onconova
Afrezza
Dacogen
Arikace
Rigosertib
The Best- And Worst-Performing Biotech Stocks, June 28 to July 5
Forbes
Mon, 07/8/13 - 11:02 am
biotech
ONYX Pharmaceuticals
Celldex
Novavax
Puma Biotechnology
Endocyte
Alnylam
Bluebird Bio
Dyax
Medivation
Clovis Oncology
Achillion
Insmed
Arena Pharmaceuticals
Avanir
Receptos
Synergy Pharmaceuticals
ChemoCentryx
Idenix
MiMedx
Portola Pharmaceuticals
Insmed retreats after Arikace results
The Fly on the Wall
Mon, 07/1/13 - 12:39 pm
Insmed
Arikace
Novartis

Pages